Last updated: September 25, 2023
Sponsor: University of Colorado, Denver
Overall Status: Active - Recruiting
Phase
N/A
Condition
Hyponatremia
Treatment
Flashback CRI T1 Tablet
Clinical Study ID
NCT04911465
20-2755
Ages 31-26 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Children 31 days through 26 years (inclusive) of age who undergo Trauma Red (highestlevel) activation or Trauma Level 1 (mid-level) activation at Children's Hospital Coloradoor Children's National Medical Center.
Exclusion
Exclusion Criteria:
- Pregnant patients
- Incarcerated patients
- Patients who object to study participation at any time
- Limited access to or compromised monitoring sites for non-invasive finger sensors
- Brain death (GCS 3 with fixed, dilated pupils)
Study Design
Total Participants: 300
Treatment Group(s): 1
Primary Treatment: Flashback CRI T1 Tablet
Phase:
Study Start date:
May 01, 2021
Estimated Completion Date:
June 30, 2024
Connect with a study center
Children's Hospital Colorado
Aurora, Colorado 80045
United StatesActive - Recruiting
Children's National Hospital
Washington, District of Columbia 20010
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.